Dexrazoxane does not affect treatment outcome in Non-Hodgkins Lymphoma patients

American Journal of Hematology, 05/08/2012

he findings suggest that use of dexrazoxane during anthracycline–containing chemotherapy does not have a significant effect on treatment outcome in lymphoma patients.

Print Article Summary Cat 2 CME Report